Penn Medicine University of Pennsylvania Health System — Philadelphia, Pennsylvania

Penn Medicine University of Pennsylvania Health System is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Penn Medicine University of Pennsylvania Health System has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Castration-resistant Prostate Cancer.

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Medicine University of Pennsylvania Health System?

Penn Medicine University of Pennsylvania Health System has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Medicine University of Pennsylvania Health System conducted?

Penn Medicine University of Pennsylvania Health System has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-resistant Prostate Cancer.

Is Penn Medicine University of Pennsylvania Health System accredited by Crixeo Health?

Penn Medicine University of Pennsylvania Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Penn Medicine University of Pennsylvania Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.